SPDR(R) S&P(R) Pharmaceuticals ETF

$41.65

Compare similar ETFs

Fund Size
Dividend
Fees
Current
(R) S&P(R) Pharmaceuticals ETF XPH
Fund Size
$165 Million
Dividend
1.6%
Fees
0.35%

Average metrics of all companies in portfolio

Compare to
Market
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $61.6 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 1.51 %
Beta Indicates the relationship between the price performance of a share and the market. 0.6599
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 25.67
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -33.02
Profitable Companies 52
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 201.67
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 5.54
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 10.21
Compare to
Market
Enterprise Value to EBIT Enterprise Value divided by EBIT 6.57
Enterprise Value to Revenue Enterprise value divided by revenue 14.7
Total Debt to Enterprise Value Total debt divided by enterprise value 0.21
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 1.4103
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -378.99%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
Return on Equity Equity divided by market cap. 4901.51%
Return on Assets Indicates a company's profitability in relation to its total assets. 193.33%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 420.77%

Industries

Healthcare 91.3%
Finance 2.2%
N/A 6.5%

Market cap

Micro Cap 5%
Small Cap 35%
Mid Cap 28%
Large Cap 25%
Mega Cap 7%

46 Investments

P/E-Ratio
Total Investment
Weight
Corcept Therapeutics Inc logo

CORT - Manufacturing

Corcept Therapeutics Inc

P/E-Ratio
54.9
Total Investment
$12.1 Million
Weight
7.4%
Tarsus Pharmaceuticals Inc logo

TARS - Manufacturing

Tarsus Pharmaceuticals Inc

P/E-Ratio
-8.5
Total Investment
$6.03 Million
Weight
3.7%
Perrigo Co PLC logo

PRGO - Manufacturing

Perrigo Co PLC

P/E-Ratio
-20.7
Total Investment
$5.93 Million
Weight
3.7%
Bristol-Myers Squibb Co logo

BMY - Manufacturing

Bristol-Myers Squibb Co

P/E-Ratio
-16.7
Total Investment
$5.93 Million
Weight
3.7%
Zoetis Inc logo

ZTS - Manufacturing

Zoetis Inc

P/E-Ratio
29.2
Total Investment
$5.92 Million
Weight
3.6%
Johnson & Johnson logo

JNJ - Manufacturing

Johnson & Johnson

P/E-Ratio
17.3
Total Investment
$5.92 Million
Weight
3.6%
Elanco Animal Health Inc logo

ELAN - Manufacturing

Elanco Animal Health Inc

P/E-Ratio
18.3
Total Investment
$5.87 Million
Weight
3.6%
Intra-Cellular Therapies Inc logo

ITCI - Manufacturing

Intra-Cellular Therapies Inc

P/E-Ratio
-182.1
Total Investment
$5.84 Million
Weight
3.6%
Eli Lilly & Co logo

LLY - Manufacturing

Eli Lilly & Co

P/E-Ratio
66.3
Total Investment
$5.84 Million
Weight
3.6%
Organon & Co logo

OGN - Manufacturing

Organon & Co

P/E-Ratio
3.5
Total Investment
$5.77 Million
Weight
3.6%
Pfizer Inc logo

PFE - Manufacturing

Pfizer Inc

P/E-Ratio
17.7
Total Investment
$5.73 Million
Weight
3.5%
Prestige Consumer Healthcare Inc logo

PBH - Manufacturing

Prestige Consumer Healthcare Inc

P/E-Ratio
19.4
Total Investment
$5.69 Million
Weight
3.5%
Axsome Therapeutics Inc logo

AXSM - Manufacturing

Axsome Therapeutics Inc

P/E-Ratio
-18.3
Total Investment
$5.67 Million
Weight
3.5%
Merck & Co Inc logo

MRK - Manufacturing

Merck & Co Inc

P/E-Ratio
11.9
Total Investment
$5.59 Million
Weight
3.4%
Royalty Pharma PLC logo

RPRX - Manufacturing

Royalty Pharma PLC

P/E-Ratio
13.8
Total Investment
$5.51 Million
Weight
3.4%
Viatris Inc logo

VTRS - Finance and Insurance

Viatris Inc

P/E-Ratio
-2.8
Total Investment
$5.48 Million
Weight
3.4%
Jazz Pharmaceuticals PLC logo

JAZZ - Manufacturing

Jazz Pharmaceuticals PLC

P/E-Ratio
13.7
Total Investment
$5.38 Million
Weight
3.3%
Edgewise Therapeutics Inc logo

EWTX - Manufacturing

Edgewise Therapeutics Inc

P/E-Ratio
-10.0
Total Investment
$4.79 Million
Weight
3.0%
Pacira BioSciences Inc logo

PCRX - Manufacturing

Pacira BioSciences Inc

P/E-Ratio
-10.8
Total Investment
$4.47 Million
Weight
2.8%
Harmony Biosciences Holdings Inc logo

HRMY - Manufacturing

Harmony Biosciences Holdings Inc

P/E-Ratio
17.1
Total Investment
$4.47 Million
Weight
2.8%
Amphastar Pharmaceuticals Inc logo

AMPH - Manufacturing

Amphastar Pharmaceuticals Inc

P/E-Ratio
8.7
Total Investment
$4.2 Million
Weight
2.6%
Supernus Pharmaceuticals Inc logo

SUPN - Manufacturing

Supernus Pharmaceuticals Inc

P/E-Ratio
28.9
Total Investment
$3.17 Million
Weight
2.0%
Arvinas Inc logo

ARVN - Manufacturing

Arvinas Inc

P/E-Ratio
-11.5
Total Investment
$3.14 Million
Weight
1.9%
ANI Pharmaceuticals Inc logo

ANIP - Manufacturing

ANI Pharmaceuticals Inc

P/E-Ratio
-58.3
Total Investment
$3 Million
Weight
1.9%
Harrow Inc logo

HROW - Manufacturing

Harrow Inc

P/E-Ratio
-50.1
Total Investment
$2.84 Million
Weight
1.7%